BRAFV600E突变与甲状腺乳头状癌临床病理特征及不良预后的相关性
尹梦婷， 李素平 - 国际放射医学核医学杂志, 2020 - ijrmnm.com
… 目前认为 PTC 的最佳治疗方案是手术切除,131I 治疗及甲状腺激素替代抑制… thyroid cancer,
papillary thyroid cancer (PTC), medullary … Evaluation of molecular diagnostic approaches for the …
papillary thyroid cancer (PTC), medullary … Evaluation of molecular diagnostic approaches for the …
局部晚期或转移性儿童及青少年分化型甲状腺癌的基因特征与临床特征及131I 疗效的关系
孙迪， 孙郁青， 张鑫， 黄丽莎， 林岩松 - 中国癌症杂志, 2022 - china-oncology.com
… : The molecular characteristics of differentiated thyroid cancer (… 甲状腺乳头状癌(papillary
thyroid carcinoma,PTC)占比90%… does not ever concentrate RAI (no uptake outside the thyroid …
thyroid carcinoma,PTC)占比90%… does not ever concentrate RAI (no uptake outside the thyroid …
2015 年美国甲状腺学会《 成人甲状腺结节与分化型甲状腺癌诊治指南》 解读: 分化型甲状腺癌131I 治疗新进展
林岩松， 李娇 - 中国癌症杂志, 2016 - china-oncology.com
… 转导通路,参 与PTC的发生,发展[25-26],而且与PTC的多灶 性,包膜… regional lymph node
metastasis in papillary thyroid cancer [J]… and molecular profile of differentiated thyroid cancers with …
metastasis in papillary thyroid cancer [J]… and molecular profile of differentiated thyroid cancers with …
BRD4 通过SHH 信号通路诱导甲状腺癌细胞增殖, 侵袭与迁移
冀凯伦， 刘琪， 牟作峰 - 中国癌症杂志, 2017 - china-oncology.com
… the effect of BRD4 in papillary thyroid cancer (PTC), and search … 的治疗,主要以甲状腺癌
根治切除术联合131I放射治疗以及… : state of the art of its molecular characterization[J]. Biochim …
根治切除术联合131I放射治疗以及… : state of the art of its molecular characterization[J]. Biochim …
碘难治性分化型甲状腺癌靶向药物治疗进展
李盼丽， 宋少莉 - 国际放射医学核医学杂志, 2016 - ijrmnm.com
… and a lower level of iodine uptake now use targeted drugs … of molecular targeted therapy
about refractory thyroid cancer. … 乳头状甲状腺癌渊papillary thyroid carcinoma袁PTC冤和滤泡…
about refractory thyroid cancer. … 乳头状甲状腺癌渊papillary thyroid carcinoma袁PTC冤和滤泡…
不同年龄儿童及青少年分化型甲状腺癌患者的临床病理学特征与131I 治疗分析
齐萌芳， 田甜， 黄蕤 - 中国癌症杂志, 2022 - china-oncology.com
… thyroid carcinoma,DTC), 主要包括甲状腺乳头状癌(papillary thyroid carcinoma,PTC)和甲状腺
滤泡癌(follicular thyroid … : radiological pattern, molecular genetics, response to therapy, and …
滤泡癌(follicular thyroid … : radiological pattern, molecular genetics, response to therapy, and …
131I在复发性甲状腺乳头状癌临床诊治中的价值
景正军， 张亚奇， 别爽， 樊倩妤， 陈健 - 肿瘤防治研究, 2022 - zlfzyj.com
… accurate location and iodine uptake evaluation of recurrence … 分化型甲状腺癌(differentiated
thyroid cancer, DTC)经验性131I… 总之,PTC预后良好,但复发并不罕见,131I 在复发性PTC多学科…
thyroid cancer, DTC)经验性131I… 总之,PTC预后良好,但复发并不罕见,131I 在复发性PTC多学科…
131I 难治性分化型甲状腺癌的再分化治疗
程凌霄， 陈立波 - 中国癌症杂志, 2016 - china-oncology.com
… thyroid carcinoma,PTC)和甲状腺滤泡状癌 (follicular thyroid … reuptake in radioactive
iodine-refractory thyroid carcinoma[J]. … the molecular diagnosis and targeted therapy of thyroid …
iodine-refractory thyroid carcinoma[J]. … the molecular diagnosis and targeted therapy of thyroid …
碘难治性甲状腺癌的诊治进展
林岩松， 杨雪 - 中国癌症杂志, 2017 - china-oncology.com
… (differentiated thyroid cancer,DTC)经过规范的手术,选择性131I… 癌(papillary thyroid cancer,
PTC)及滤泡状癌(follicular thyroid … enhanced radioiodine uptake in advanced thyroid cancer[J]. …
PTC)及滤泡状癌(follicular thyroid … enhanced radioiodine uptake in advanced thyroid cancer[J]. …
血清甲状腺球蛋白抗体在分化型甲状腺癌中的产生机制及其临床价值
赵翊含， 林岩松， 赵新明 - 国际放射医学核医学杂志, 2022 - ijrmnm.com
… 包括乳头状甲状 腺癌(papillary thyroid carcinoma,PTC),滤泡状… of 131I of differentiated thyroid
cancer after surgery[J]. China … cancer treated with total thyroidectomy without 131I ablation[J…
cancer after surgery[J]. China … cancer treated with total thyroidectomy without 131I ablation[J…